Eam Global Investors LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$20.56 - $63.12 $341,686 - $1.05 Million	-16,619 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$28.14 - $73.01 $860,155 - $2.23 Million	-30,567 Reduced 64.78%	16,619 $1.05 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $1.22 Million - $1.62 Million	-46,610 Reduced 49.69%	47,186 $1.33 Million
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $178,831 - $295,693	-10,260 Reduced 9.86%	93,796 $2.49 Million
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $97,219 - $162,812	-8,068 Reduced 7.2%	104,056 $1.91 Million
Q4 2018 Feb 13, 2019	SELL	$10.74 - $19.7 $217,538 - $399,023	-20,255 Reduced 15.3%	112,124 $1.39 Million
Q3 2018 Nov 08, 2018	BUY	$14.0 - $20.3 $358,176 - $519,355	25,584 Added 23.96%	132,379 $2.54 Million
Q2 2018 Aug 03, 2018	BUY	$6.37 - $14.02 $680,284 - $1.5 Million	106,795 New	106,795 $1.45 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.